Concord Medical Services Holdings
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other tre… Read more
Concord Medical Services Holdings (CCM) - Net Assets
Latest net assets as of June 2025: $1.72 Billion USD
Based on the latest financial reports, Concord Medical Services Holdings (CCM) has net assets worth $1.72 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.73 Billion) and total liabilities ($5.01 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.72 Billion |
| % of Total Assets | 25.57% |
| Annual Growth Rate | 22.12% |
| 5-Year Change | -32.62% |
| 10-Year Change | 12.83% |
| Growth Volatility | 229.52 |
Concord Medical Services Holdings - Net Assets Trend (2007–2024)
This chart illustrates how Concord Medical Services Holdings's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Concord Medical Services Holdings (2007–2024)
The table below shows the annual net assets of Concord Medical Services Holdings from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.62 Billion | -7.40% |
| 2023-12-31 | $1.75 Billion | -13.33% |
| 2022-12-31 | $2.02 Billion | -26.54% |
| 2021-12-31 | $2.74 Billion | +14.28% |
| 2020-12-31 | $2.40 Billion | +27.08% |
| 2019-12-31 | $1.89 Billion | -16.92% |
| 2018-12-31 | $2.27 Billion | +124.05% |
| 2017-12-31 | $1.01 Billion | -17.60% |
| 2016-12-31 | $1.23 Billion | -14.09% |
| 2015-12-31 | $1.43 Billion | -20.35% |
| 2014-12-31 | $1.80 Billion | -26.11% |
| 2013-12-31 | $2.44 Billion | +4.03% |
| 2012-12-31 | $2.34 Billion | +14.90% |
| 2011-12-31 | $2.04 Billion | -11.46% |
| 2010-12-31 | $2.30 Billion | +6.88% |
| 2009-12-31 | $2.15 Billion | +281.18% |
| 2008-12-31 | $565.02 Million | +943.76% |
| 2007-12-31 | $54.13 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Concord Medical Services Holdings's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 437283200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $105.00K | % |
| Other Comprehensive Income | $-77.35 Million | % |
| Other Components | $2.17 Billion | % |
| Total Equity | $-2.28 Billion | 100.00% |
Concord Medical Services Holdings Competitors by Market Cap
The table below lists competitors of Concord Medical Services Holdings ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
OY Nofar Energy Ltd
TA:NOFR
|
$16.42 Million |
|
Yjn Co.,Ltd.
TWO:3191
|
$16.42 Million |
|
MMP Industries Limited
NSE:MMP
|
$16.42 Million |
|
Targovax ASA
LSE:0RIS
|
$16.43 Million |
|
Aptamer Sciences Inc
KQ:291650
|
$16.41 Million |
|
Star Media Group Bhd
KLSE:6084
|
$16.40 Million |
|
4C Group AB
ST:4C
|
$16.40 Million |
|
Maxeon Solar Technologies Ltd
NASDAQ:MAXN
|
$16.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Concord Medical Services Holdings's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -2,121,945,000 to -2,280,390,000, a change of -158,445,000.
- Net loss of 308,243,000 reduced equity.
- Share repurchases of 510,522,000 reduced equity.
- New share issuances of 510,522,000 increased equity.
- Other comprehensive income decreased equity by 11,930,000.
- Other factors increased equity by 161,728,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-308.24 Million | -13.52% |
| Share Repurchases | $510.52 Million | -22.39% |
| Share Issuances | $510.52 Million | +22.39% |
| Other Comprehensive Income | $-11.93 Million | -0.52% |
| Other Changes | $161.73 Million | +7.09% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Concord Medical Services Holdings's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | $0.95 | $3.65 | x |
| 2008-12-31 | $294.89 | $3.65 | x |
| 2009-12-31 | $865.55 | $3.65 | x |
| 2010-12-31 | $452.98 | $3.65 | x |
| 2011-12-31 | $407.97 | $3.65 | x |
| 2012-12-31 | $1322.26 | $3.65 | x |
| 2013-12-31 | $14153.60 | $3.65 | x |
| 2014-12-31 | $11967.70 | $3.65 | x |
| 2015-12-31 | $9300.29 | $3.65 | x |
| 2016-12-31 | $8035.24 | $3.65 | x |
| 2017-12-31 | $6462.53 | $3.65 | x |
| 2018-12-31 | $3025.76 | $3.65 | x |
| 2019-12-31 | $-848.40 | $3.65 | x |
| 2020-12-31 | $-15.18 | $3.65 | x |
| 2021-12-31 | $-9410.14 | $3.65 | x |
| 2022-12-31 | $-12801.96 | $3.65 | x |
| 2023-12-31 | $-14573.80 | $3.65 | x |
| 2024-12-31 | $-15662.02 | $3.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Concord Medical Services Holdings utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -80.28%
- • Asset Turnover: 0.06x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-4.74%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 13.99% | 46.03% | 0.11x | 2.68x | $22.57 Million |
| 2009 | 5.80% | 42.69% | 0.12x | 1.13x | $-90.55 Million |
| 2010 | 5.87% | 33.22% | 0.15x | 1.21x | $-91.11 Million |
| 2011 | -11.11% | -47.77% | 0.19x | 1.24x | $-408.45 Million |
| 2012 | 6.07% | 27.05% | 0.13x | 1.78x | $-79.82 Million |
| 2013 | 4.04% | 15.25% | 0.14x | 1.92x | $-126.55 Million |
| 2014 | 6.94% | 20.55% | 0.21x | 1.65x | $-55.05 Million |
| 2015 | -5.63% | -12.70% | 0.17x | 2.59x | $-217.34 Million |
| 2016 | -22.46% | -57.55% | 0.14x | 2.77x | $-378.48 Million |
| 2017 | -30.44% | -85.90% | 0.10x | 3.71x | $-377.72 Million |
| 2018 | -53.70% | -123.04% | 0.04x | 10.48x | $-278.62 Million |
| 2019 | 0.00% | -154.79% | 0.05x | 0.00x | $-294.77 Million |
| 2020 | 0.00% | -181.17% | 0.04x | 0.00x | $-337.73 Million |
| 2021 | 0.00% | -55.89% | 0.08x | 0.00x | $-134.42 Million |
| 2022 | 0.00% | -103.72% | 0.08x | 0.00x | $-303.26 Million |
| 2023 | 0.00% | -55.39% | 0.09x | 0.00x | $-85.46 Million |
| 2024 | 0.00% | -80.28% | 0.06x | 0.00x | $-80.20 Million |
Industry Comparison
This section compares Concord Medical Services Holdings's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Concord Medical Services Holdings (CCM) | $1.72 Billion | 13.99% | 2.91x | $16.41 Million |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |